NCT05599646

Brief Summary

Patients undergoing HD are mostly physically inactive and have reduced functional capacities compared to healthy individuals which contributes to a decreased quality of life and consequently increases the risk of mortality

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 31, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

May 13, 2025

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

October 24, 2022

Last Update Submit

May 9, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • change in patients weekly step count

    Step count will be assessed using a pedometer.

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

  • change in fatigue level

    Brief Fatigue Inventory questionnaire will evaluate the level of current fatigue and usual fatigue in the last 24 hours.A score of 0 means no fatigue and a score of 10 means the highest level of fatigue. The total score of fatigue was obtained through summing up the score of questions 2e10 (nine items) and dividing by nine

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

Secondary Outcomes (6)

  • change in sleep quality

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

  • change in functional status

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

  • change in heart rate

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

  • change in respiratory rate

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

  • change in systolic blood pressure

    will be measured at baseline and after intervention [(after 12 weeks of walking program)]

  • +1 more secondary outcomes

Study Arms (3)

traditional pedometer group

EXPERIMENTAL
Behavioral: traditional pedometer based walking intervention

gamified smartphone pedometer group

EXPERIMENTAL
Behavioral: gamified pedometer based walking intervention

control group

NO INTERVENTION

Interventions

Participants were recommended to monitor their step count using traditional pedometer and to increase their steps by 10% compared with the prior week. the intervention will continue for 12 weeks

traditional pedometer group

Participants were recommended to monitor their step count using gamified pedometer, earn money, compete friends and to increase their steps by 10% compared with the prior week. the intervention will continue for 12 weeks

gamified smartphone pedometer group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • under- going conventional hemodialysis three times a week,
  • hemodialysis period of three month or more,
  • having smartphone aneroid access (second group),
  • Available for telephone follow-up ,
  • ability to read and write ,
  • and being ambulatory,
  • Patients using a cane or other assistive device will be eligible and Patients provided informed consent to participate.

You may not qualify if:

  • The study will exclude patients with
  • unstable angina,
  • those with lower-limb amputation
  • and those using wheelchairs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing Mansoura University

Al Mansurah, Egypt

Location

Related Publications (1)

  • Elzeky MEH, Ramadan El-Shaboury RH, Salameh B, Samaan E, F M Shahine N, Abdelhamid A. Effects of gamified versus pedometer-based walking intervention on physical activity, fatigue, and sleep quality among hemodialysis patients: a quasi-experimental study. BMC Nephrol. 2025 Mar 3;26(1):108. doi: 10.1186/s12882-025-04012-7.

MeSH Terms

Conditions

Sedentary BehaviorFatigue

Condition Hierarchy (Ancestors)

BehaviorSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer at medical surgical nursing

Study Record Dates

First Submitted

October 24, 2022

First Posted

October 31, 2022

Study Start

October 31, 2022

Primary Completion

September 30, 2023

Study Completion

March 30, 2025

Last Updated

May 13, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations